Successfully treated severe COVID-19 and invasive aspergillosis in early hematopoietic cell transplantation setting.

So far, we do not have any published database regarding HCT patients during the present pandemic. We herein describe the first case of COVID-19 presenting in the early hematopoietic cell transplantation (HCT) setting.